Trials / Completed
CompletedNCT05413265
Alaska Native Family-Based, Financial Incentives Intervention for Smoking Cessation
Alaska Native Family-Based, Financial Incentives Intervention for Smoking Cessation: Phases 1 and 2
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the proposed study is to develop and beta-test a culturally adapted, Alaska Native family-based incentives intervention for smoking cessation.
Detailed description
Aim 1 has two phases: In Aim 1/Phase 1, we will use qualitative in-depth individual interviews to culturally tailor and adapt the intervention. These interviews (n=36) will include Alaska Native or American Indian (AN/AI) people who smoke (n=12), family members of Alaska Native people who smoke (n=12), and stakeholders from the Alaska Tribal Health System (n=12). We will present the proposed financial incentives intervention to each group and ask them questions about possible concerns, recruitment strategies, possible risks, and appeal to Alaska Native culture. For the stakeholders, we will also ask about potential barriers of implementing the program into their organization/department. In Aim 1/Phase 2, we will beta-test and refine the intervention with 10 dyads comprising of an AN/AI person who smokes and their family member. The beta-test will last for 6 months. The dyad will receive cash rewards of increasing value over the course of the 6 months for negative, completed smoking status checks. A negative check-in counts as self-reported abstinence and biochemically confirmed abstinence: saliva cotinine sample measuring ≤ 30 n/ml (negative Alere iScreen result) and expired carbon monoxide sample measuring ≤ 6 ppm with iCOQuit device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Phases 1 and 2 | Phase 1 participants will help inform the cultural adaptation of the study design and materials. Phase 2 will enroll 10 dyads (20 individuals) of AN/AI people who smoke and a family member. Dyad participants will help beta-test the feasibility and acceptability of the financial incentives intervention. |
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2024-04-28
- Completion
- 2024-04-28
- First posted
- 2022-06-10
- Last updated
- 2025-03-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05413265. Inclusion in this directory is not an endorsement.